Literature DB >> 16117781

Production of lysophosphatidic acid in blister fluid: involvement of a lysophospholipase D activity.

Juliette Mazereeuw-Hautier1, Sandra Gres, Madie Fanguin, Clotilde Cariven, Josette Fauvel, Bertrand Perret, Hugues Chap, Jean-Pierre Salles, Jean-Sébastien Saulnier-Blache.   

Abstract

Lysophosphatidic acid (LPA) is present in abundance in serum resulting from platelet activation and is also found in other biological fluids. LPA controls numerous cellular responses and plays a role in specific functions such as wound healing, especially in the skin. Nevertheless, its presence in the skin has never been investigated. Since re-epithelialization occurs after blister rupture, we tested the presence of endogenous LPA in blister fluid and investigated a possible mechanism for its biosynthesis and biological functions. Using a radioenzymatic assay, LPA was detected in 33 blister fluids originating from 24 bullous dermatoses, and at higher concentrations than in plasma. In parallel, blister fluids contained a lysophospholipase D (LPLD) activity but no detectable phospholipase A2 activity. The expressions of the LPLD autotaxin (ATX) and of LPA1-receptor (LPA1-R) were greatly increased in blister skin when compared with normal skin. Finally, LPA was found to have a positive effect on the migration of cultured keratinocytes. These results show that LPA is present in blister fluid synthesized by the LPLD ATX. Due to its ability to enhance keratinocyte migration, LPA in blister fluid could, via the LPA1-R, play an important role in re-epithelialization occurring after blister rupture.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16117781      PMCID: PMC1885457          DOI: 10.1111/j.0022-202X.2005.23855.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  43 in total

1.  Phosphatidic acid that accumulates in platelet-derived growth factor-stimulated Balb/c 3T3 cells is a potential mitogenic signal.

Authors:  K Fukami; T Takenawa
Journal:  J Biol Chem       Date:  1992-06-05       Impact factor: 5.157

2.  Identification of two secreted phospholipases A2 in human epidermis.

Authors:  E Maury; M C Prévost; M F Simon; D Redoules; I Ceruti; R Tarroux; M Charveron; H Chap
Journal:  J Invest Dermatol       Date:  2000-05       Impact factor: 8.551

Review 3.  International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclature.

Authors:  Jerold Chun; Edward J Goetzl; Timothy Hla; Yasuyuki Igarashi; Kevin R Lynch; Wouter Moolenaar; Susan Pyne; Gabor Tigyi
Journal:  Pharmacol Rev       Date:  2002-06       Impact factor: 25.468

Review 4.  Cytokines and bullous pemphigoid.

Authors:  L D'Auria; P Cordiali Fei; F Ameglio
Journal:  Eur Cytokine Netw       Date:  1999-06       Impact factor: 2.737

5.  Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior.

Authors:  J J Contos; N Fukushima; J A Weiner; D Kaushal; J Chun
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

6.  Production of lysophosphatidic acids by lysophospholipase D in human follicular fluids of In vitro fertilization patients.

Authors:  A Tokumura; M Miyake; Y Nishioka; S Yamano; T Aono; K Fukuzawa
Journal:  Biol Reprod       Date:  1999-07       Impact factor: 4.285

7.  Alpha2-adrenergic receptor-mediated release of lysophosphatidic acid by adipocytes. A paracrine signal for preadipocyte growth.

Authors:  P Valet; C Pagès; O Jeanneton; D Daviaud; P Barbe; M Record; J S Saulnier-Blache; M Lafontan
Journal:  J Clin Invest       Date:  1998-04-01       Impact factor: 14.808

8.  Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells.

Authors:  O Fourcade; M F Simon; C Viodé; N Rugani; F Leballe; A Ragab; B Fournié; L Sarda; H Chap
Journal:  Cell       Date:  1995-03-24       Impact factor: 41.582

9.  Phospholipid profiles of human colon cancer using 31P magnetic resonance spectroscopy.

Authors:  T E Merchant; J N Kasimos; P W de Graaf; B D Minsky; L W Gierke; T Glonek
Journal:  Int J Colorectal Dis       Date:  1991-05       Impact factor: 2.571

10.  Serum lysophosphatidic acid is produced through diverse phospholipase pathways.

Authors:  Junken Aoki; Akitsu Taira; Yasukazu Takanezawa; Yasuhiro Kishi; Kotaro Hama; Tatsuya Kishimoto; Koji Mizuno; Keijiro Saku; Ryo Taguchi; Hiroyuki Arai
Journal:  J Biol Chem       Date:  2002-09-26       Impact factor: 5.157

View more
  17 in total

1.  An Autotaxin/Lysophosphatidic Acid/Interleukin-6 Amplification Loop Drives Scleroderma Fibrosis.

Authors:  Flavia V Castelino; Gretchen Bain; Veronica A Pace; Katharine E Black; Leaya George; Clemens K Probst; Lance Goulet; Robert Lafyatis; Andrew M Tager
Journal:  Arthritis Rheumatol       Date:  2016-12       Impact factor: 10.995

Review 2.  Fibrosis--a lethal component of systemic sclerosis.

Authors:  Yuen Yee Ho; David Lagares; Andrew M Tager; Mohit Kapoor
Journal:  Nat Rev Rheumatol       Date:  2014-04-22       Impact factor: 20.543

Review 3.  Role of the lysophospholipid mediators lysophosphatidic acid and sphingosine 1-phosphate in lung fibrosis.

Authors:  Barry S Shea; Andrew M Tager
Journal:  Proc Am Thorac Soc       Date:  2012-07

4.  Amelioration of dermal fibrosis by genetic deletion or pharmacologic antagonism of lysophosphatidic acid receptor 1 in a mouse model of scleroderma.

Authors:  Flavia V Castelino; Jon Seiders; Gretchen Bain; Sarah F Brooks; Christopher D King; James S Swaney; Daniel S Lorrain; Jerold Chun; Andrew D Luster; Andrew M Tager
Journal:  Arthritis Rheum       Date:  2011-05

5.  Domain interplay mediated by an essential disulfide linkage is critical for the activity and secretion of the metastasis-promoting enzyme autotaxin.

Authors:  Silvia Jansen; Maria Andries; Rita Derua; Etienne Waelkens; Mathieu Bollen
Journal:  J Biol Chem       Date:  2009-03-27       Impact factor: 5.157

6.  LysoPtdOH enhances CXCL16 production stimulated by LPS from macrophages and regulates T cell migration.

Authors:  Shijun Kang; Chunlan Yang; Rongcheng Luo
Journal:  Lipids       Date:  2008-10-02       Impact factor: 1.880

Review 7.  Autotaxin.

Authors:  Jean A Boutin; Gilles Ferry
Journal:  Cell Mol Life Sci       Date:  2009-06-09       Impact factor: 9.261

Review 8.  Recent advances in targeting the autotaxin-lysophosphatidate-lipid phosphate phosphatase axis in vivo.

Authors:  Matthew G K Benesch; Xiaoyun Tang; Ganesh Venkatraman; Raie T Bekele; David N Brindley
Journal:  J Biomed Res       Date:  2015-08-28

Review 9.  Autotaxin-Lysophosphatidic Acid: From Inflammation to Cancer Development.

Authors:  Silvia Anahi Valdés-Rives; Aliesha González-Arenas
Journal:  Mediators Inflamm       Date:  2017-12-21       Impact factor: 4.711

10.  Lysophosphatidic acid promotes cell migration through STIM1- and Orai1-mediated Ca2+(i) mobilization and NFAT2 activation.

Authors:  Ralph Jans; Laura Mottram; Darren L Johnson; Anna M Brown; Stephen Sikkink; Kehinde Ross; Nick J Reynolds
Journal:  J Invest Dermatol       Date:  2012-10-25       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.